Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Current Taxes (2019 - 2022)

Historic Current Taxes for Nurix Therapeutics (NRIX) over the last 4 years, with Q3 2022 value amounting to $41000.0.

  • Nurix Therapeutics' Current Taxes rose 1081.08% to $41000.0 in Q3 2022 from the same period last year, while for Aug 2022 it was $41000.0, marking a year-over-year increase of 1081.08%. This contributed to the annual value of $75000.0 for FY2021, which is 135.14% up from last year.
  • As of Q3 2022, Nurix Therapeutics' Current Taxes stood at $41000.0, which was up 1081.08% from $26000.0 recorded in Q2 2022.
  • Nurix Therapeutics' 5-year Current Taxes high stood at $325000.0 for Q1 2021, and its period low was $26000.0 during Q2 2022.
  • Moreover, its 4-year median value for Current Taxes was $41000.0 (2022), whereas its average is $77555.6.
  • In the last 5 years, Nurix Therapeutics' Current Taxes surged by 12424.24% in 2020 and then tumbled by 8369.23% in 2022.
  • Over the past 4 years, Nurix Therapeutics' Current Taxes (Quarter) stood at $33000.0 in 2019, then surged by 124.24% to $74000.0 in 2020, then increased by 1.35% to $75000.0 in 2021, then crashed by 45.33% to $41000.0 in 2022.
  • Its Current Taxes was $41000.0 in Q3 2022, compared to $26000.0 in Q2 2022 and $53000.0 in Q1 2022.